|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
EMD Biosciences, Inc. Enters Into A Cooperative Agreement With The RZPD German Resource Center for Genome Research; EMD Biosciences Antibody Products Now Available From RZPD
10/19/2005 5:12:14 PM
EMD Biosciences, Inc. (EMD Biosciences; www.emdbiosciences.com), a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced it has entered into a cooperative agreement with the RZPD Deutsches Ressourcenzentrum fur Genomforschung (German Resource Center for Genome Research; www.rzpd.de), a not-for-profit service center known for its high-quality genomics- and proteomics-specific tools and services, including the comprehensive GenomeCube(TM) resource database, for academic and industrial researchers. EMD Biosciences is part of the Life Science and Analytics (LSA) division of Merck KGaA (Darmstadt, Germany; www.merck.de) and operates as EMD Biosciences, Inc. in North America and Merck Biosciences outside North America.
|
|
|
|
|
|
|
|
|
|
|